California Public Employees Retirement System Travere Therapeutics, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$14.11 - $26.4 $1.4 Million - $2.63 Million	-99,500 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$23.37 - $31.77 $241,061 - $327,707	-10,315 Reduced 9.39%	99,500 $2.49 Million
Q4 2020 Feb 02, 2021	BUY	$19.17 - $27.87 $2.11 Million - $3.06 Million	109,815 New	109,815 $2.99 Million

Others Institutions Holding TVTX

# of Institutions

192

Shares Held

84.5M

Call Options Held

776K

Put Options Held

900K

Armistice Capital, LLC New York, NY

7.65M
Shares

$133 Million
1.78% of portfolio
Black Rock Inc. New York, NY

7.64M
Shares

$133 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.9M
Shares

$120 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

4.68M
Shares

$81.5 Million
2.23% of portfolio
Woodline Partners LP San Francisco, CA

4.34M
Shares

$75.5 Million
0.55% of portfolio

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.12B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account